Volgende

Automatisch afspelen

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

2 Bekeken • 07/14/23
Delen
insluiten
administrator
administrator
abonnees
0

Visit http://www.ecancer.org for more

Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen